Maxygen Revenue Growth: -24.39%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MAXY Revenue Growth Rankings
| Overall | 6th percentile | 4152 of 4424 |
| Sector | 3rd percentile | 841 of 868 in Services |
| Industry | 9th percentile | 10 of 11 in Research Services |
MAXY Revenue Growth Range, Past 5 Years
| Minimum | -81.27% | Sep 2005 |
| Maximum | 477.01% | Sep 2006 |
| Average |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these MAXY related companies
MAXY News
$MAXY http://stks.co/29DH vol laden nr7 friday w/ pos hard sell below $5.4
about 13 days ago by traderdigs
about 13 days ago by traderdigs
Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome
Nov 09, 4:30PM Business Wire
Nov 09, 4:30PM Business Wire
$MAXY set to rally after breaking out of long consolidation rectangle. Looks to close the December 2010 gap at $6.80
about 124 days ago by checkthetechs
about 124 days ago by checkthetechs
Maxygen announces final rejection of '804 patent in inter partes reexamination
Oct 10, 5:17PM FlyOnTheWall
Oct 10, 5:17PM FlyOnTheWall
Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding
Oct 10, 5:00PM Business Wire
Oct 10, 5:00PM Business Wire
Some Swings and Scalps for Today: $RCKB $IPAS $MAXY $DGII http://stk.ly/keEf56
about 240 days ago by SharePlanner
about 240 days ago by SharePlanner
=> $MAXY $5.23 LEE KENNETH B JR director P 3,000 @ $5.23 amnt $15,690 proc'd $0 6/1/2011
about 256 days ago by canarionyc
about 256 days ago by canarionyc
$MAXY--Director purchased 20,000 shares at $5.16. Last trade is $5.08. Nice float, decent avg volume. Do your own research.
about 265 days ago by MicroInsider
about 265 days ago by MicroInsider
$MAXY $5.08 STEIN ISAAC director P 20,000 @ $5.16 amnt $103,200 proc'd ($1,600) 5/19/2011
about 268 days ago by canarionyc
about 268 days ago by canarionyc
$MAXY tries for radiation exposure BARDA award w/ MAXY-34: http://stk.ly/jd0fhC Didn't a Canadian licensee already fail with this attempt?
about 284 days ago by BioDueDiligence
about 284 days ago by BioDueDiligence
$MAXY http://chart.ly/xbp2y4t Spec biotech showing tight weekly closes after big move; like to see this - good support
about 312 days ago by Kenshreve
about 312 days ago by Kenshreve
Astellas exercises option to buy out $MAXY JV for 76m http://stk.ly/egeX5B Nice deal, but makes the 20m deal w/ $CDXS look even worse
about 332 days ago by BioDueDiligence
about 332 days ago by BioDueDiligence
$MAXY 4q2010 results: http://stk.ly/dQTWE9 Does this structure and strategy make sense to anyone besides the 5 guys still getting paychecks?
about 340 days ago by BioDueDiligence
about 340 days ago by BioDueDiligence
$maxy if this can take out 4.28 this can be really good for gap fill
about 397 days ago by danshep55
about 397 days ago by danshep55
$maxy started buying 4.10 coming out tight range with vol can squeeze hard 20nil float
about 397 days ago by danshep55
about 397 days ago by danshep55
$maxy on watch for tommrow. no position . scared of that gap down . but will watch for strength tommrowo
about 405 days ago by danshep55
about 405 days ago by danshep55
$BPW (gap), $CATM (stop: $11.18), $CYD (gap), $MAXY (200-day MA); 29 breakouts but movers carry characteristics of exhaustion runs
about 685 days ago by fallondpicks
about 685 days ago by fallondpicks
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MAXY | 5.49 | -0.18 | -3.17% | 163.05M |
| RRST | 4.30 | 0.00 | 0.01% | 74.61M |
| EDAP | 2.11 | -0.04 | -1.86% | 27.68M |
| ENSG | 26.48 | -0.52 | -1.93% | 555.55M |
| ROCM | 8.08 | 0.12 | 1.51% | 99.06M |
| DROOY | 6.15 | 0.02 | 0.33% | 236.71M |
| FREE | 0.64 | -0.06 | -8.59% | 4.15M |
| LLNW | 3.98 | -0.12 | -2.81% | 453.32M |
| ATML | 9.78 | -0.11 | -1.11% | 4.52B |
| BRCD | 5.80 | -0.14 | -2.36% | 2.85B |
